Name | (3-hydroxy-4-methoxycarbonyl-2,5-dimethylphenyl) 3-formyl-2,4-dihydroxy-6-methylbenzoate |
---|---|
Synonyms |
Atranorine
Atranorin 3-Formyl-2,4-dihydroxy-6-methylbenzoic Acid 3-Hydroxy-4-(methoxycarbonyl)-2,5-dimethylphenyl Ester Atranorinsaeure-methylester Parmelin EINECS 207-527-7 Benzoic acid, 3-formyl-2,4-dihydroxy-6-methyl-, 3-hydroxy-4- (methoxycarbonyl)-2,5-dimethylphenyl ester Usnarin Benzoic acid, 3-formyl-2,4-dihydroxy-6-methyl-, 3-hydroxy-4-(methoxycarbonyl)-2,5-dimethylphenyl ester Benzoic acid, 3-formyl-2,4-dihydroxy-6-methyl-, 3-hydroxy-4-(methoxycarbonyl)-2,5-dimethylphenyl ester (9CI) 3-Hydroxy-4-(methoxycarbonyl)-2,5-dimethylphenyl 3-formyl-2,4-dihydroxy-6-methylbenzoate Parmelin acid Atranoric acid Usnarin acid Antranoric acid |
Description | Atranorin is a lichen secondary metabolite. Atranorin inhibits lung cancer cell motility and tumorigenesis by affecting AP-1, Wnt, and STAT signaling and suppressing RhoGTPase activity[1][2]. |
---|---|
Related Catalog | |
Target |
RhoGTPase[1] |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 535.7±50.0 °C at 760 mmHg |
Melting Point | 156-158ºC |
Molecular Formula | C19H18O8 |
Molecular Weight | 374.341 |
Flash Point | 189.3±23.6 °C |
Exact Mass | 374.100159 |
PSA | 130.36000 |
LogP | 6.14 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.644 |
Hazard Codes | Xi |
---|
Precursor 0 | |
---|---|
DownStream 9 | |